Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
Location status: Recruiting
Location contact
Mingguang Zhang
CONTACT
Xishan Wang
CONTACT
Xishan Wang, M.D.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06350370
Natural orifice specimen extraction surgery (NOSES) has gained widespread recognition among scholars and has gradually been promoted and popularized around the world. However, the development of NOSES is still in the exploratory stage and there is a lack of strong evidence from evidence-based medicine to support its feasibility and safety, which has greatly affected its clinical application and development. Based on this, at the call of Professor Xishan Wang, the Chinese NOSES Alliance conducted a large retrospective clinical study involving multiple centers. By summarizing the NOSES cases of nearly 100 centers in China, the study aims to clarify the current status of NOSES surgery in China. Additionally, a comprehensive analysis and summary was conducted by combining the basic information of NOSES patients, perioperative data, postoperative pathological data, and follow-up information to further demonstrate the safety and feasibility of NOSES in the treatment of colorectal cancer. This study also provides more real and objective evidence-based medicine support for the promotion and development of NOSES surgery.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100021, China
Location status: Recruiting
Mingguang Zhang
CONTACT
Xishan Wang
CONTACT
Xishan Wang, M.D.
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We perform laparoscopic colorectal cancer resection, intracorporeal anastomosis and transanal or transvaginal specimen extraction
Time frame: 30 days after surgery
Rate of complications occurred within 30 days after surgery
Time frame: 7 days
Total time of the operation
Time frame: 7 days
Estimated blood loss during the surgery
Time frame: 7 days
Time to first flatus after surgery
Time frame: 7 days
Time to first stool after surgery
Time frame: 7 days
Length of stay after surgery
Time frame: 3 year
3-year disease free survival
Time frame: 3 year
3-year overall survival
Contact information is provided by the study sponsor or research team.
Mingguang Zhang
CONTACT
Xishan Wang
CONTACT
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04912765
Adenocarcinoma, Carcinoma
Singapore
View Trial DetailsNCT06411691
Colonic Diseases, Colonic Neoplasms
Baltimore, Maryland, United States
View Trial DetailsNCT07736495
Colonic Diseases, Colorectal Cancer
Cairo, Egypt
View Trial DetailsNCT07321106
Advanced Colorectal Cancer, CRC
Duarte, California, United States
View Trial Details